Teewinot Capital Advisers L.L.C. Boosts Holdings in The Cigna Group (NYSE:CI)
Teewinot Capital Advisers L.L.C. grew its position in The Cigna Group (NYSE:CI – Free Report) by 80.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 76,032 shares of the health services provider’s stock after buying an additional 33,801 shares during the period. The Cigna Group accounts for approximately 3.6% of Teewinot Capital Advisers L.L.C.’s investment portfolio, making the stock its 11th largest position. Teewinot Capital Advisers L.L.C.’s holdings in The Cigna Group were worth $21,335,000 at the end of the most recent quarter.
Other hedge funds have also made changes to their positions in the company. Bank Julius Baer & Co. Ltd Zurich raised its holdings in shares of The Cigna Group by 63,861.5% in the 2nd quarter. Bank Julius Baer & Co. Ltd Zurich now owns 39,406,651 shares of the health services provider’s stock valued at $11,057,506,000 after purchasing an additional 39,345,041 shares in the last quarter. Moneta Group Investment Advisors LLC raised its stake in The Cigna Group by 154,255.6% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,954,841 shares of the health services provider’s stock worth $3,961,117,000 after acquiring an additional 11,947,096 shares in the last quarter. Norges Bank acquired a new stake in The Cigna Group during the 4th quarter worth $963,542,000. Envestnet Asset Management Inc. raised its stake in The Cigna Group by 853.9% during the 1st quarter. Envestnet Asset Management Inc. now owns 1,928,419 shares of the health services provider’s stock worth $50,464,000 after acquiring an additional 1,726,261 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its stake in The Cigna Group by 22.7% during the 1st quarter. Ameriprise Financial Inc. now owns 4,346,293 shares of the health services provider’s stock worth $1,110,597,000 after acquiring an additional 804,805 shares in the last quarter. Hedge funds and other institutional investors own 85.32% of the company’s stock.
The Cigna Group Price Performance
CI stock traded down $1.52 during trading on Friday, reaching $256.42. 371,241 shares of the company were exchanged, compared to its average volume of 1,660,371. The company has a market cap of $75.03 billion, a P/E ratio of 14.55, a PEG ratio of 0.97 and a beta of 0.56. The Cigna Group has a 52-week low of $240.50 and a 52-week high of $340.11. The stock’s 50 day moving average price is $291.30 and its 200 day moving average price is $282.67. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.71 and a current ratio of 0.71.
The Cigna Group (NYSE:CI – Get Free Report) last released its quarterly earnings data on Thursday, November 2nd. The health services provider reported $6.77 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.11. The firm had revenue of $49.05 billion for the quarter, compared to the consensus estimate of $48.14 billion. The Cigna Group had a net margin of 2.79% and a return on equity of 12.62%. The firm’s revenue was up 8.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.04 earnings per share. As a group, analysts predict that The Cigna Group will post 24.82 earnings per share for the current fiscal year.
The Cigna Group Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 21st. Shareholders of record on Wednesday, December 6th will be given a dividend of $1.23 per share. This represents a $4.92 dividend on an annualized basis and a yield of 1.92%. The ex-dividend date is Tuesday, December 5th. The Cigna Group’s payout ratio is currently 27.75%.
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on the stock. Edward Jones lowered shares of The Cigna Group from a “buy” rating to a “hold” rating in a research note on Thursday, August 17th. Cantor Fitzgerald lifted their price objective on shares of The Cigna Group from $310.00 to $334.00 and gave the company a “neutral” rating in a research note on Friday, November 3rd. Sanford C. Bernstein lifted their price objective on shares of The Cigna Group from $326.00 to $330.00 in a research note on Tuesday, October 10th. StockNews.com upgraded shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a research note on Friday, November 3rd. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $327.00 price objective on shares of The Cigna Group in a research note on Thursday, November 30th. Five investment analysts have rated the stock with a hold rating, five have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, The Cigna Group currently has an average rating of “Moderate Buy” and a consensus target price of $336.40.
Read Our Latest Stock Report on The Cigna Group
The Cigna Group Profile (Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider The Cigna Group, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and The Cigna Group wasn’t on the list.
While The Cigna Group currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Click the link below and we’ll send you MarketBeat’s guide to investing in 5G and which 5G stocks show the most promise.
Original: MarketBeat News Feed: Teewinot Capital Advisers L.L.C. Boosts Holdings in The Cigna Group (NYSE:CI)